B. Delahunt
Papers
1
Total Citations
33
H-Index
1
About
B. Delahunt is a leading figure in urological pathology, whose work has fundamentally reshaped the diagnosis and management of prostate cancer. His research centers on the critical intersection of advanced imaging and histopathology, aiming to refine the accuracy of cancer detection and staging. In a landmark 2021 study involving over 1,100 men, Delahunt demonstrated that while multiparametric magnetic resonance imaging (mpMRI) is a powerful tool, it can still miss clinically significant prostate cancers. His team’s pivotal contribution was showing that adding prostate-specific membrane antigen PET/CT (PSMA PET/CT) to the diagnostic workflow provides crucial complementary information, improving the detection of aggressive disease before surgery. This finding, which has garnered over 30 citations, directly informs current clinical guidelines and has a tangible impact on patient care by reducing the risk of underdiagnosis. Through this and related work, Delahunt has established himself as a key voice in the drive toward more precise, imaging-guided prostate cancer management, helping to ensure that men receive the most accurate diagnosis and appropriate treatment.
Research Focus
Key Achievements
Top Papers
- 1